[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2009 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-Nov-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Sep-2009 [#3]
Profit Trend
QoQ- 18.81%
YoY- -9.38%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 667,895 317,560 1,300,796 976,890 646,928 313,716 1,305,646 -36.11%
PBT 32,758 12,431 81,436 53,948 44,521 20,184 90,599 -49.34%
Tax -8,931 -3,122 -19,709 -14,337 -11,305 -5,491 -29,190 -54.69%
NP 23,827 9,309 61,727 39,611 33,216 14,693 61,409 -46.89%
-
NP to SH 24,054 9,307 60,191 38,279 32,219 14,522 60,031 -45.73%
-
Tax Rate 27.26% 25.11% 24.20% 26.58% 25.39% 27.20% 32.22% -
Total Cost 644,068 308,251 1,239,069 937,279 613,712 299,023 1,244,237 -35.60%
-
Net Worth 417,306 439,675 431,158 407,610 400,063 402,378 388,297 4.93%
Dividend
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Div 50,290 - 39,585 28,885 28,881 - 28,881 44.88%
Div Payout % 209.07% - 65.77% 75.46% 89.64% - 48.11% -
Equity
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Net Worth 417,306 439,675 431,158 407,610 400,063 402,378 388,297 4.93%
NOSH 107,001 106,977 106,987 106,984 106,968 107,015 106,968 0.02%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin 3.57% 2.93% 4.75% 4.05% 5.13% 4.68% 4.70% -
ROE 5.76% 2.12% 13.96% 9.39% 8.05% 3.61% 15.46% -
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
RPS 624.19 296.85 1,215.84 913.11 604.78 293.15 1,220.58 -36.12%
EPS 22.48 8.70 56.26 35.78 30.12 13.57 56.12 -45.75%
DPS 47.00 0.00 37.00 27.00 27.00 0.00 27.00 44.85%
NAPS 3.90 4.11 4.03 3.81 3.74 3.76 3.63 4.91%
Adjusted Per Share Value based on latest NOSH - 107,049
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
RPS 46.34 22.03 90.26 67.78 44.89 21.77 90.59 -36.11%
EPS 1.67 0.65 4.18 2.66 2.24 1.01 4.17 -45.75%
DPS 3.49 0.00 2.75 2.00 2.00 0.00 2.00 45.09%
NAPS 0.2895 0.3051 0.2992 0.2828 0.2776 0.2792 0.2694 4.92%
Price Multiplier on Financial Quarter End Date
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Date 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 -
Price 4.98 4.27 4.00 4.09 3.80 3.45 3.36 -
P/RPS 0.80 1.44 0.33 0.45 0.63 1.18 0.28 101.73%
P/EPS 22.15 49.08 7.11 11.43 12.62 25.42 5.99 139.70%
EY 4.51 2.04 14.07 8.75 7.93 3.93 16.70 -58.31%
DY 9.44 0.00 9.25 6.60 7.11 0.00 8.04 11.32%
P/NAPS 1.28 1.04 0.99 1.07 1.02 0.92 0.93 23.80%
Price Multiplier on Announcement Date
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Date 11/08/10 26/05/10 19/02/10 13/11/09 21/08/09 08/05/09 27/02/09 -
Price 4.95 4.71 4.05 3.93 4.00 3.82 2.73 -
P/RPS 0.79 1.59 0.33 0.43 0.66 1.30 0.22 135.04%
P/EPS 22.02 54.14 7.20 10.98 13.28 28.15 4.86 174.57%
EY 4.54 1.85 13.89 9.10 7.53 3.55 20.56 -63.56%
DY 9.49 0.00 9.14 6.87 6.75 0.00 9.89 -2.72%
P/NAPS 1.27 1.15 1.00 1.03 1.07 1.02 0.75 42.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment